Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Etrasimod dose-ranging study in Japanese UC patients
NCT05061446Phase 2Completed
- Sponsor
- Pfizer
- Start
- Sep 2021
- Primary completion
- Oct 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etrasimod in ulcerative colitis (UC), sponsored by Pfizer. Started Sep 2021; status: completed.
02
Drugs
etrasimod
03
Conditions
ulcerative colitis (UC)
Beyond the preview
Go deeper on NCT05061446.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05061446.